Earnings calls

NGL Fine Chem concall ledger

Every earnings call for NGLFINE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

NGLFINE · 2 transcripts · Healthcare · latest Q2 FY26

Q2 FY26Published 18 Nov 2025Call held 18 Nov 2025

NGLFINE Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹120.26 cr+29% YoYEBITDA₹17.16 cr+48% YoYEBITDA Margin14.27%PAT₹9.63 cr−2% YoY

Revenue (Q2 FY26) ₹120 cr (+29% YoY); EBITDA (Q2 FY26) ₹17 cr (+48% YoY); EBITDA Margin (Q2 FY26) 14.27%. Q2 FY26 Revenue from operations grew 28.64% YoY to INR120.26 crores.

Read full transcript & analysis

Q4 FY25Published 26 May 2025Call held 26 May 2025

NGLFINE Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹94.97 cr−5% YoYEBITDA₹6.32 cr−60% YoYEBITDA Margin6.7%−9% YoYPAT₹0.54 cr

Revenue (Q4 FY25) ₹95 cr (−5% YoY); EBITDA (Q4 FY25) ₹6 cr (−60% YoY); EBITDA Margin (Q4 FY25) 6.7% (−9% YoY). FY25 Revenue from operations grew 8.7% to INR368.26 crores.

Read full transcript & analysis